Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Quality of Life of Informal Caregivers of Hematopoietic Cell Transplant Recipients

Kareem Jamani, MD, Lynn E. Onstad, ScM, Rachel B. Salit, MD, Mary E. Flowers, MD, Paul A. Carpenter, MD, Stephanie J. Lee, MD PhD

Blood (2017) 130 (Supplement 1): 280.

https://doi.org/10.1182/blood.V130.Suppl_1.280.280

Published: 2017

Journal Articles

Genetic Risk Factors for Sclerotic Graft-Versus-Host Disease

Yoshihiro Inamoto, MD PhD, Paul J. Martin, MD, Mary E. Flowers, MD, Stephanie J. Lee, MD MPH, Paul A. Carpenter, MD, Edus Houston Warren, MD PhD, Michael Boeckh, MD, Barry E. Storer, PhD, David Levine, PhD, Wenhong Fan, Lue Ping Zhao, PhD, John A. Hansen, MD

Blood (2014) 124 (21): 665.

https://doi.org/10.1182/blood.V124.21.665.665

Published: 2014

Journal Articles

Posttransplant Cyclophosphamide for Prevention of Graft-Versus-Host Disease after HLA-Matched Related and Unrelated Donor Peripheral Blood Stem Cell Transplantation

Marco Mielcarek, MD, Terrence Furlong, Paul V. O'Donnell, MD PhD, Barry E. Storer, PhD, Rainer F. Storb, MD, Paul A. Carpenter, MD, Paul J. Martin, MD

Blood (2014) 124 (21): 1161.

https://doi.org/10.1182/blood.V124.21.1161.1161

Published: 2014

Journal Articles

Efficacy and Safety Of Lower-Dose Glucocorticoids For Initial Treatment Of Acute Graft-Versus-Host Disease: A Randomized Controlled Trial

Marco Mielcarek, MD, Terrence Furlong, Barry E. Storer, PhD, Margaret L. Green, MD, Paul A. Carpenter, MD, George B McDonald, MD, Mary E. D. Flowers, MD, Rainer Storb, MD, Frederick R. Appelbaum, MD, Michael Boeckh, MD, Paul J. Martin, MD

Blood (2013) 122 (21): 703.

https://doi.org/10.1182/blood.V122.21.703.703

Published: 2013

Journal Articles

Failure-Free Survival After Initial Systemic Treatment Of Chronic GVHD

Yoshihiro Inamoto, MD, PhD, Paul J. Martin, MD, Brenda M. Sandmaier, MD, Sahika Aki, MD, Paul A. Carpenter, MD, Stephanie J. Lee, MD, MPH, Barry E. Storer, PhD, Mary E. D. Flowers, MD

Blood (2013) 122 (21): 2053.

https://doi.org/10.1182/blood.V122.21.2053.2053

Published: 2013

Journal Articles

Recommended Tools for Joint Chronic Graft-Versus-Host Disease: Results From the Chronic Gvhd Consortium

Yoshihiro Inamoto, MD, PhD, Xiaoyu Chai, MS, Brenda Kurland, PhD, Daniel J. Weisdorf, MD, Paul J. Martin, MD, David Jacobsohn, MD, Joseph Pidala, MD, MS, Jeanne Palmer, MD, Sally Arai, MD, Corey Cutler, MD, MPH, FRCPC, Madan Jagasia, MBBS, MS, Mary E.D. Flowers, MD, Mukta Arora, MD, Steven Z. Pavletic, MD, Georgia B. Vogelsang, MD, Stephanie J. Lee, MD, MPH, Paul A. Carpenter, MD

Blood (2012) 120 (21): 464.

https://doi.org/10.1182/blood.V120.21.464.464

Published: 2012

Journal Articles

Outcome of Transplantation for Acute Leukemia in Down Syndrome

Blood (2012) 120 (21): 1991.

https://doi.org/10.1182/blood.V120.21.1991.1991

Published: 2012

Journal Articles

Calculated NIH Response Correlates with Changes in Patient-Reported Symptoms but Not with Quality of Life: Results From the Chronic Gvhd Consortium

Yoshihiro Inamoto, MD, Corey S. Cutler, MD, MPH, FRCPC, Xiaoyu Chai, MS, Mukta Arora, MD, Paul J. Martin, MD, Joseph Pidala, MD, MS, Jeanne Palmer, MD, Steven Z. Pavletic, MD, Madan H. Jagasia, MD, David Jacobsohn, MD, Paul A. Carpenter, MD, Mary E.D. Flowers, MD, Nandita Khera, MD, Georgia B. Vogelsang, MD, Daniel J. Weisdorf, MD, Barry Storer, PhD, Stephanie J. Lee, MD, MPH

Blood (2011) 118 (21): 1988.

https://doi.org/10.1182/blood.V118.21.1988.1988

Published: 2011

Journal Articles

Incidence, Risk Factors and Outcomes of Sclerotic Chronic Graft-Versus-Host Disease (GVHD) Phenotype After Allogeneic Hematopoietic Cell Transplantation

Yoshihiro Inamoto, MD, Barry Storer, PhD, Effie W. Petersdorf, MD, Paul A. Carpenter, MD, Stephanie J. Lee, MD, MPH, Lee Nelson, MD, Brenda M. Sandmaier, MD, Paul J. Martin, MD, Mary E.D. Flowers, MD

Blood (2011) 118 (21): 322.

https://doi.org/10.1182/blood.V118.21.322.322

Published: 2011

Journal Articles

A Phase 1 Open Label, Dose Escalation Study of Nilotinib in Steroid Dependent/Refractory Chronic Graft-Versus-Host Disease

George L. Chen, MD, Paul A. Carpenter, MD, Raewyn Broady, MBChB, FRACP, Tara B. Gregory, MD, Sally Arai, MD, Laura Johnston, MD, Mary E.D. Flowers, MD, Jan H. Beumer, PharmD, PhD, Jodie Mendolsohn, Xin Zhou, Spenser H. Perloff, Joanne M Otani, RN, MSN, David B Miklos, MD, PhD

Blood (2011) 118 (21): 1986.

https://doi.org/10.1182/blood.V118.21.1986.1986

Published: 2011

Journal Articles

Characterization of Chronic Graft-Versus-Host Disease and Duration of Immunosuppression After Cord Blood Transplantation,

Laura F Newell, MD, Mary E.D. Flowers, MD, Ted Gooley, Filippo Milano, MD, PhD, Paul A. Carpenter, MD, Paul J Martin, MD, Colleen Delaney, MD

Blood (2011) 118 (21): 4077.

https://doi.org/10.1182/blood.V118.21.4077.4077

Published: 2011

Journal Articles

Change in NIH Skin Score 0–3 Correlates with Provider- and Patient-Reported Skin Changes and Overall Survival: Results From the Chronic Gvhd Consortium

David Jacobsohn, MD, Stephanie J. Lee, MD, MPH, Brenda Kurland, PhD, Corey S. Cutler, MD, MPH, FRCPC, Joseph Pidala, MD, MS, Paul A. Carpenter, MD, Shawn Chai, Sally Arai, MD, Mukta Arora, MD, Jeanne Palmer, MD, Paul J. Martin, MD, Steven Z. Pavletic, MD, Mary E.D. Flowers, MD

Blood (2011) 118 (21): 151.

https://doi.org/10.1182/blood.V118.21.151.151

Published: 2011

Journal Articles

Risk Factors for the Development of Acute and National Institute of Health (NIH) Chronic Graft-Versus-Host Disease (GVHD).

Mary E.D. Flowers, MD, Barry E. Storer, PhD, Stephanie J. Lee, MD, MPH, Paulo Vidal Campregher, MD, Afonso Celso Vigorito, MD, PhD, Paul A. Carpenter, MD, Marco Mielcarek, MD, Frederick R. Appelbaum, MD, Paul J. Martin, MD

Blood (2009) 114 (22): 345.

https://doi.org/10.1182/blood.V114.22.345.345

Published: 2009

Journal Articles

Sub-Morphologic Evidence of Disease Prior to Stem Cell Transplantation Correlates with Inferior Post Transplant Outcome in Childhood Acute Myeloid Leukemia.

Abby R. Rosenberg, MD, Wendy Leisenring, Sc.D., Jean E Sanders, MD, Ann E Woolfrey, MD, Paul A. Carpenter, MD, Denise A. Wells, MD, Michael R. Loken, PhD, Soheil Meshinchi, MD, PhD

Blood (2009) 114 (22): 328.

https://doi.org/10.1182/blood.V114.22.328.328

Published: 2009

Journal Articles

Use of Fluid-Ventilated, Gas-Permeable Scleral Lens (SL) for Management of Severe Keratoconjunctivitis Sicca Secondary to Chronic Graft-Versus-Host Disease.

Kikuchi Takahide, MD, Pablo Miguel Parker, MD, Michael Wu, MD, Paul A. Carpenter, MD, Barbara Stehr, ARNP, Perry Rosenthal, MD, Paul J. Martin, MD, Stephen J. Forman, MD, Mary E.D. Flowers, MD

Blood (2006) 108 (11): 2913.

https://doi.org/10.1182/blood.V108.11.2913.2913

Published: 2006

Journal Articles

A Pilot Study Evaluating the Safety and Efficacy of Imatinib Given Early after Transplant for High-Risk Philadelphia Chromosome-Postive Leukemias.

Paul A. Carpenter, MD, David S. Snyder, MD, Mary E. Flowers, MD, Jean E. Sanders, MD, Paul J. Martin, MD, Jerald P. Radich, MD

Blood (2005) 106 (11): 1095.

https://doi.org/10.1182/blood.V106.11.1095.1095

Published: 2005

Journal Articles

Chronic Cutaneous GVHD Does Not Correlate with Frequency and FoxP3 Gene Expression of Regulatory T Cells.

Peter Haeusermann, MD, Laura Tabellini, Mary E. Flowers, MD, Paul J. Martin, MD, Paul A. Carpenter, MD, John A. Hansen, MD

Blood (2005) 106 (11): 1819.

https://doi.org/10.1182/blood.V106.11.1819.1819

Published: 2005

NARROW

Quality of Life of Informal Caregivers of Hematopoietic Cell Transplant Recipients

Genetic Risk Factors for Sclerotic Graft-Versus-Host Disease

Posttransplant Cyclophosphamide for Prevention of Graft-Versus-Host Disease after HLA-Matched Related and Unrelated Donor Peripheral Blood Stem Cell Transplantation

Efficacy and Safety Of Lower-Dose Glucocorticoids For Initial Treatment Of Acute Graft-Versus-Host Disease: A Randomized Controlled Trial

Failure-Free Survival After Initial Systemic Treatment Of Chronic GVHD

Recommended Tools for Joint Chronic Graft-Versus-Host Disease: Results From the Chronic Gvhd Consortium

Outcome of Transplantation for Acute Leukemia in Down Syndrome

Calculated NIH Response Correlates with Changes in Patient-Reported Symptoms but Not with Quality of Life: Results From the Chronic Gvhd Consortium

Incidence, Risk Factors and Outcomes of Sclerotic Chronic Graft-Versus-Host Disease (GVHD) Phenotype After Allogeneic Hematopoietic Cell Transplantation

A Phase 1 Open Label, Dose Escalation Study of Nilotinib in Steroid Dependent/Refractory Chronic Graft-Versus-Host Disease

Characterization of Chronic Graft-Versus-Host Disease and Duration of Immunosuppression After Cord Blood Transplantation,

Change in NIH Skin Score 0–3 Correlates with Provider- and Patient-Reported Skin Changes and Overall Survival: Results From the Chronic Gvhd Consortium

Risk Factors for the Development of Acute and National Institute of Health (NIH) Chronic Graft-Versus-Host Disease (GVHD).

Sub-Morphologic Evidence of Disease Prior to Stem Cell Transplantation Correlates with Inferior Post Transplant Outcome in Childhood Acute Myeloid Leukemia.

Use of Fluid-Ventilated, Gas-Permeable Scleral Lens (SL) for Management of Severe Keratoconjunctivitis Sicca Secondary to Chronic Graft-Versus-Host Disease.

A Pilot Study Evaluating the Safety and Efficacy of Imatinib Given Early after Transplant for High-Risk Philadelphia Chromosome-Postive Leukemias.

Chronic Cutaneous GVHD Does Not Correlate with Frequency and FoxP3 Gene Expression of Regulatory T Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only